Overview
Kateryna Bazaka practices practicing medicine in Canberra, Australia.
Her clinical expertise encompasses Pheochromocytoma, Bullae, Necrosis, and Neuroendocrine Tumor.
She is actively involved in clinical research, co-authoring 59 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kateryna Bazaka
Is Kateryna Bazaka a top-rated expert for Pheochromocytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Kateryna Bazaka is classified as an Experienced expert for Pheochromocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kateryna Bazaka participate in research or clinical trials?
Yes. Kateryna Bazaka has published 59 articles and abstracts on conditions like Pheochromocytoma. You can view a list of Kateryna Bazaka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BullaeMs. Bazaka isExperienced. Learn about Bullae.
- NecrosisMs. Bazaka isExperienced. Learn about Necrosis.
- Neuroendocrine TumorMs. Bazaka isExperienced. Learn about Neuroendocrine Tumor.
- PheochromocytomaMs. Bazaka isExperienced. Learn about Pheochromocytoma.